Baillie Gifford HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 423 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.

Baillie Gifford ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$43,415
+144616.7%
7630.0%0.00%
Q3 2022$30
-16.7%
763
-6.4%
0.00%
Q2 2022$36
+16.1%
815
+4.6%
0.00%
Q1 2022$310.0%7790.0%0.00%
Q4 2021$31
-13.9%
779
-11.5%
0.00%
Q3 2021$36
-18.2%
880
-8.5%
0.00%
Q2 2021$44
+4.8%
962
-4.4%
0.00%
Q1 2021$42
+2.4%
1,006
+5.5%
0.00%
Q4 2020$419540.00%